Product NDC: | 0703-3069 |
Proprietary Name: | Epirubicin Hydrochloride |
Non Proprietary Name: | Epirubicin Hydrochloride |
Active Ingredient(s): | 200 mg/100mL & nbsp; Epirubicin Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-3069 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065331 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070809 |
Package NDC: | 0703-3069-11 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0703-3069-11) > 100 mL in 1 VIAL, SINGLE-USE |
NDC Code | 0703-3069-11 |
Proprietary Name | Epirubicin Hydrochloride |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0703-3069-11) > 100 mL in 1 VIAL, SINGLE-USE |
Product NDC | 0703-3069 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Epirubicin Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20070809 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | EPIRUBICIN HYDROCHLORIDE |
Strength Number | 200 |
Strength Unit | mg/100mL |
Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |